Pharmaceutical & Biotechnology

Overview
Reviews
Schedule Demo
Related Resources

Unlocking the power of connected global HCP, institutional, clinical, diversity and inclusion, research and clinical trial information.

Relationships Matter

The digitization of healthcare has impacted more than how information is shared. Building long-term, mutually beneficial relationships with external stakeholders, medical experts, and key opinion leaders (KOLs) is more difficult than ever. Those relationships are key to Medical Affairs and Medical Science Liaisons (MSLs) for a multitude of reasons. The ability to identify and influence those medical experts quickly has repercussions that echo beyond business goals. That ability is what stands between a life science or medical device company’s therapies or treatments, and the patients hoping for a better outcome.

Creating an Equitable Future

Clinical trials test the safety and efficacy of treatment options in drug therapies, medical devices, and therapeutics for patients and establish new standards of care. Ultimately, clinical trials drive progress forward and provide patients with early access to new treatments that lead to better health equity, access to care, and outcomes. If the latter is to be true, then it’s paramount that the patient segments and investigators represented in the clinical trial process be as diverse and inclusive as possible.

Trusted by Industry Leaders

“The partnership with H1 has allowed us to gather important data sources all in one system. What once took us 400 hours was reduced to 40 hours.”

VP, Strategic Initiatives
|
Top 20 Pharma Company

Request a Demo

Product Demo Screenshots